Sandro Holzer
Head Director, Development Bioconjugates Lonza
Sandro Holzer studied biochemistry at the Swiss Federal Institute of Technology (ETH Zurich, Switzerland) and earned his Ph.D. in structural biology from the University of Cambridge (United Kingdom). He began his industrial career in process development at Lonza in Visp, Switzerland. In the current position, as Head of Development Bioconjugates, he leads early phase CMC activities for conjugate programs, including process and analytical development, scale up, and GMP manufacturing support.
Seminars
Tuesday 24th February 2026
From Novel Conjugates to IND: Solving Early‑Phase CMC Challenges
3:00 pm
- Lonza’s broad CMC experience across ADCs and emerging conjugate modalities enables de‑risked, accelerated early‑phase development to IND
- Real‑world customer use case: Resolving clearance liabilities and translating bench success into robust, scalable chromatography operations
- Fit‑for‑purpose analytics for complex conjugates: Closing method gaps to enable confident characterization, release, and stability control
